ZSHK was invited to participate in the 6th China Pharmaceutical Innovation and Investment Conference, CEO Dr. Li Ming was invited by the conference organizing committee to serve“Innovative drug basic research and achievement transformation roadshow”host and host“Explore innovative drugs—"The Chinese Model of Basic Research Results Transformation" roundtable discussion, with Zhang Ao, Dean of School of Pharmacy, Shanghai Jiao Tong University, Song Ruilin, Executive Chairman of China Pharmaceutical Innovation Promotion Association, and Zhou Wen, Chief Biologist and Senior Vice President of Beijing Jiakesi New Drug Research and Development Co., Ltd. Lai and Ye Weitao, managing partner of Lize Capital, discussed the implementation path of the transformation of basic research results from different perspectives.